Filter
Investigational Therapies
These compounds and their uses are investigational and have not been approved by the US Food and Drug Administration. Efficacy and safety have not been established. The information presented should not be construed as a recommendation for use. The relevance of findings in preclinical studies to humans is currently being evaluated.
Showing results
Phase III
BREAST
GASTROINTESTINAL
GENITOURINARY
GYNECOLOGIC
HEAD/NECK
HEMATOLOGY
LUNG
MELANOMA
PAN TUMOR
SOLID TUMOR
Phase II
BREAST
GASTROINTESTINAL
GENITOURINARY
GYNECOLOGIC
HEAD/NECK
HEMATOLOGY
LUNG
MELANOMA
PAN TUMOR
SOLID TUMOR
Phase I
BREAST
Atezolizumab
(anti-PD-L1 MAb)
(RG7446)
BREAST
GASTROINTESTINAL
GENITOURINARY
GYNECOLOGIC
HEAD AND NECK
HEMATOLOGY
SOLID TUMOR
GASTROINTESTINAL
Atezolizumab
(anti-PD-L1 MAb)
(RG7446)
BREAST
GASTROINTESTINAL
GENITOURINARY
GYNECOLOGIC
HEAD AND NECK
HEMATOLOGY
SOLID TUMOR
GENITOURINARY
Atezolizumab
(anti-PD-L1 MAb)
(RG7446)
BREAST
GASTROINTESTINAL
GENITOURINARY
GYNECOLOGIC
HEAD AND NECK
HEMATOLOGY
SOLID TUMOR
GYNECOLOGIC
Atezolizumab
(anti-PD-L1 MAb)
(RG7446)
BREAST
GASTROINTESTINAL
GENITOURINARY
GYNECOLOGIC
HEAD AND NECK
HEMATOLOGY
SOLID TUMOR
HEAD/NECK
Atezolizumab
(anti-PD-L1 MAb)
(RG7446)
BREAST
GASTROINTESTINAL
GENITOURINARY
GYNECOLOGIC
HEAD AND NECK
HEMATOLOGY
SOLID TUMOR
HEMATOLOGY
Atezolizumab
(anti-PD-L1 MAb)
(RG7446)
BREAST
GASTROINTESTINAL
GENITOURINARY
GYNECOLOGIC
HEAD AND NECK
HEMATOLOGY
SOLID TUMOR
LUNG
MELANOMA
PAN TUMOR
SOLID TUMOR
Atezolizumab
(anti-PD-L1 MAb)
(RG7446)
BREAST
GASTROINTESTINAL
GENITOURINARY
GYNECOLOGIC
HEAD AND NECK
HEMATOLOGY
SOLID TUMOR
aDeveloped in collaboration with Array
BioPharma. bIgnyta, Inc acquisition. cJoint
project with AbbVie. cDeveloped in collaboration with
Exelixis. eDeveloped in collaboration with Chugai.
fDeveloped in collaboration with BioNTech.
Current
as of April 22, 2020. The trial information is taken from
ClinicalTrials.gov.
Reference
- Roche first-quarter results 2020 presentation, https://www.roche.com/dam/jcr:f5b0e8e3-66fb-4155-85ff-ec1b012fb46c/en/irp200422.pdf. Accessed April 24, 2020.